Clinical Trial

Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy

Study acronym: PPI-PROTECT
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A randomized controlled trial to assess the impact of prophylactic proton pump inhibitor use to improve esophagitis in lung cancer patients undergoing radiation. Patients will be randomized into a standard of care arm or the prophylactic proton pump (daily) arm.
Trial Details
NCT Number NCT07076914
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions Primary Lung Cancer, Non Small Cell Lung Cancer, Small Cell Lung Cancer
Enrollment 58 participants
Start Date 2025-10-02
Primary Completion 2028-01-02 (estimated)
Study Completion 2032-10-02 (estimated)
Updated on ClinicalTrials.gov 2025-07-22